changes to metabolism Flashcards

1
Q

describe the fuel storage capacity for the body for a 70kg man

A

For a 70kg man:
Glycogen= 0.2kg= 800kcal
Triacylglycerol=15kg=135,000 kcal
Protein=6kg=24,000 kcal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how many amino acids are there

A

20
essential and non essential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are essential amino acids

A

cannot be produced by the body

Arginine
Histidine
Methionine
Threonine
Valine
Leucine
Lysine
Isoleucine
Phenylalanine
Tryptophan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are non essential amino acids

A

Can be produced by the body
Alanine
Asparagine
Aspartate
Cysteine
Glutamate
Glutamine
Glycine
Proline
Serine
Tyrosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what 3 categories can essential amino acids be divided into

A
  • glucogenic:

Arginine
Histidine
Methionine
Threonine
Valine

  • ketogenic

Leucine
Lysine

  • glucogenic + ketogenic

Isoleucine
Phenylalanine
Tryptophan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what 2 groups can non essential amino acids be divided into

A
  • glucogenic

Alanine
Asparagine
Aspartate
Cysteine
Glutamate
Glutamine
Glycine
Proline
Serine

  • glucogenic + ketogenic

Tyrosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

explain alanines conversion to pyruvate

A

Alanine loses its amino group by transamination to form pyruvate catalysed by alanine aminotransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

explain asparagines conversion to oxaloacetate

A

Asparagine is hydrolysed by asparaginase, liberating ammonia and aspartate.

Aspartate loses its amino group by transamination via the enzyme aspartate aminotransferase to form oxaloacetate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

explain glutamines conversion to alpha-ketoglutarate

A

Glutamine is converted to glutamate and ammonia by the enzyme glutaminase (2).

Glutamate is converted to -ketoglutarate by oxidative deamination by glutamate dehydrogenase (1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

explain tyrosines conversion to fumarate

A

A multi-step reaction

Transamination
- Tyrosine –>Hydroxy-phenylpyruvate
- ⍺-ketoglutarate—> Glutamate

Dioxygenation:
- Hydroxy-phenylpyruvate—> Homogentisate
- O2 + Ascorbate (Vit. C)–> CO2 + H2O

Dioxygenation:
- Homogentisate–> 4-Maleylacoacetate

Isomerisation:
- 4-Maleylacoacetate–> 4-Furmarlacoacetate

Hydrolysis:
4-Furmarlacoacetate–> Fumarate and Acetoacetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

explain the causes of starvation

A

Inability to obtain food

Desire to lose weight

Clinical Situations:
- Trauma (shock)
- Burns
- Injury to face
- Tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain what happens st metabolic level during starvation

A

Blood levels of amino acids, glucose, and triacylglycerols fall

Blood insulin levels are very low, glucagon levels are very high

Both factors trigger a period of catabolism, characterised by the degradation of:
- Glycogen –> Glucose
- Triacylglycerol –> Fatty Acids and Glycerol
- Protein –> Amino Acids

This results in an interchange of substrates between:
Liver
Adipose tissue
Skeletal Muscle
Brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what determines the fates of the substrates interchanged during metabolic level of starvation

A

The fate of these substrates is determined by 2 crucial factors:​

  • The essential need to conserve glucose for those cells &tissues that really need it, such as red blood cells and brain.​
  • The need to mobilise fatty acids from adipose tissue andketone bodies from liver to supply energy to all othertissues, and for these other tissues to adapt to these non-glucose substrates.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the enzymatic changes in starvation

A

In all situations the flow of intermediates through biochemical pathways is controlled by 4 mechanisms:

  • Availability of substrates
  • Allosteric activation/inhibition of enzymes
  • Covalent modification of enzymes
  • Reciprocal Induction or repression of enzyme synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain the carbohydrate metabolism that occurs to the liver during starvation

A

Initially glycogen breakdown, then gluconeogenesis to meet the following objectives:

  • Maintain blood glucose levels
  • Sustain energy provision for the brain and other glucose requiring tissues (e.g. red blood cells).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain increased glycogen degridation in the liver during starvation

A

After a meal glucose from food is the major source of blood sugar.

A few hours after a meal blood glucose levels start to decline.

Insulin levels drop, glucagon levels increase which stimulates (by cAMP cascade) glycogen breakdown in liver.

Liver glycogen stores will last for 10-18 hours of fasting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

explain liver, increased gluconeogenesis that occurs during starvation

A

Unique ability of liver to synthesise glucose is vital during starvation and becomes increasingly active as glycogen stores are depleted.

Carbon skeletons are derived from:
- Glycerol
- Lactate
- Amino acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

explain lipid metabolism in liver starvation

A

Increased fatty acid oxidation

  • Oxidation of fatty acids derived from adipose tissue is the major source of energy for liver during starvation (this spares glucose)
  • Increased synthesis of ketone bodies

Ability of the liver to synthesise and release ketone bodies (acetyl units) is unique.

  • Synthesis is favoured when [acetyl CoA] produced via fatty acid oxidation exceeds the maximal rate of the citrate cycle.
  • KBs are vital in starvation because they can be used by other tissues and cells provided they have mitochondria.
  • Once the level of KBs in the blood is high enough, up to ⅔ of the brain can use them as fuel.
  • Utilisation of KBs reduces the need for amino acid precursors for gluconeogenesis and this decreases protein breakdown.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

explain carbohydrate metabolism of adipose tissue in starvation

A

In starvation, insulin levels decrease and hence glucose is not used for fatty acid synthesis (no signal).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

explain lipid metabolism of adipose tissue in starvation

A

Increased degradation of TAGs
- decrease insulin & increase glucagon (via cAMP cascade) causes phosphorylation and activation of hormone-sensitive lipase.

Increased release of fatty acids
- Fatty acids obtained from hydrolysis of stored adipose TAGs are released into the bloodstream.

  • Bound to albumin, they are transported to lots of tissues for use as a fuel.
  • The glycerol that is produced as the result of complete TAG hydrolysis is used for gluconeogenesis by the liver.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

explain carbohydrate metabolism in skeletal muscle in starvation

A

Glucose requirements of muscle are decreased during starvation due to very low insulin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

explain lipid metabolism in skeletal muscle during starvation

A

During first couple of weeks of starvation, muscle uses fatty acids from adipose tissue and ketone bodies from the liver as fuels.

Beyond this time period, muscle utilises only fatty acids as a fuel.

  • This spares ketone bodies for other tissues
  • Helps promote greater increase [KB] in the blood so that some parts of the brain can utilise them
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

explain protein metabolism in skeletal muscle during starvation

A

During first few weeks of starvation there is a lot of muscle wastage due to protein breakdown.

Resulting amino acids are used for gluconeogenesis.

Because the brain can utilise KBs when the [KB] in the blood is high enough, there is less of a requirement for the liver to perform gluconeogenesis.

The knock-on effect of this is that further muscle protein degradation is paused as blood [glycerol] and [lactate] are sufficient to meet the gluconeogenic needs of the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

explain the brain in starvation

A

First few weeks, brain 100% dependent on glucose.

Later, as [KB] rises, can adapt to using ketone bodies for ⅔ of its caloric requirements – reducing the need for glucose consumption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is metabolic disease

A

Inborn Errors of Metabolism

Inborn Error = An inherited genetic disorder which is either:
- Autosomal recessive
- X-linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are metabolic diseases majorly due to

A

to defects in single genes that code for enzymes that facilitate conversion of various substrates into other products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

The term inborn error of metabolism was coined by who

A

garrod in 1908

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what did garrods work prefigure

A

the ‘one gene one enzyme hypothesis’ based on his studies on the nature and inheritance of alkaptonuria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

in most metabolic disorders problems arise due to what

A

arise due to accumulation of substances which are toxic or interfere with normal function, or to the effects of a reduced/nonexistant ability to synthesize essential compounds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

explain garrods hypothesis

A

He developed an increasing interest in chemical pathology, and investigated urine chemistry as a reflection of systemic metabolism and disease.

This research, combined with the new understanding of Mendelian inheritance, evolved from an investigation of a few families with an obscure and not very dangerous disease (alkaptonuria) to the realization that a whole territory of mysterious diseases might be understood as inherited disorders of metabolism.

Over the next decade he developed an understanding of the possible nature of inherited diseases of metabolism.

He formulated the “one gene, one enzyme” hypothesis and described the nature of recessive inheritance of most enzyme defects. In 1908, the core of this work was presented as the Croonian lectures to the Royal College of Physicians, entitled Inborn Errors of Metabolism and published the following year.

Garrod expanded his metabolic studies to cover cystinuria, pentosuria, and albinism. In 1923 he summarized these studies in an expanded edition of his best known work,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is the number of overall incidence of inherited metabolic disease

A

is about 40 in 100 000 live births (1 in 2500)

32
Q

explain inherited metabolic diseases

A

Metabolic diseases are individually rare, but as a group are not uncommon

There presentations in the neonate are often non-specific at the outset

Many are treatable

Most difficult step in diagnosis is considering the possibility

33
Q

what are the major categories of inherited metabolic diseases

A

Disorders of amino acid metabolism

Disorders of carbohydrate metabolism

Lysosomal storage diseases
- Lysosome = Organelles containing enzymes for breaking down biological polymers

Disorders of peroxisomal function
- Peroxisomes = Organelles specialised in oxidation/reduction reactions using O2

Disorders of mitochondrial function

Miscellaneous (not exhaustive):
- Pelizaeus-Merzbacher disease (impaired myelin synthesis)
- Hallervorden-Spatz disease (pantothenate kinase deficiency – neurodegenerative)
- Canavan & Alexander’s diseases (myelin phospholipid impairment)
- Van der Knaap leukodystrophy (impaired myelination of brain)

34
Q

explain how inherited metabolic diseases present in the neonate

A

Acute life-threatening illness, no obvious diagnosis

Encephalopathy (large brain)
- Lethargy, irritability, coma

Vomiting

Respiratory distress

Seizures & hypertonia

Hepatomegaly (enlarged liver)

Hepatic dysfunction / jaundice

Odour, Dysmorphism, Failure to Thrive, Hiccoughs

Ambiguous genitalia

35
Q

explain what inherited metabolic disease looks like in the infant

A

Failure To Thrive

Mental retardation

Severe irritability

Impulsivity

Aggressiveness

Hyperactivity

Progressive psychomotor retardation

36
Q

how is metabolic disorder suspected

A

In any un-well, full-term infant who has no antecedent maternal fever or PROM (premature rupture of membranes)

Sick enough to warrant a blood culture or lumbar puncture

37
Q

what are the lab tests done in suspicion of a metabolic disorder

A

Glucose, electrolytes, blood gases, ketones, BUN (blood urea nitrogen), creatinine

Lactate, ammonia, bilirubin, LFT

Amino acids, organic acids, reducing substances

38
Q

explain the index of family history being an suspicion for metabolic disorders

A

Most IMDs are recessive

Consanguinity, ethnicity, inbreeding

Previous neonatal loss, miscarriage

Maternal family history:
- Males – X-linked disorders
- All – mitochondrial DNA is maternally inherited

39
Q

how can history be an index of suspicion for metabolic disorders

A

Can the symptoms be explained?

Timing of onset of symptoms
- After feeds were started?

Response to therapies

40
Q

explain lab investigation of metabolic disorders

A

Clinical Biochemistry is highly automated

  • Anion gap metabolic acidosis
  • Normal anion gap metabolic acidosis
  • Respiratory alkalosis
  • Low BUN : Creatinine
  • Hypoglycaemia
    Esp. with hepatomegaly
    Non-ketotic
41
Q

name the biochemical classifications of inherited metabolic disorders

A

Small Molecule Disease
- Carbohydrate
- Protein
- Lipid
- Nucleic Acids

Organelle
- Lysosomes
- Mitochondria
- Peroxisomes
- Cytoplasm

42
Q

what are the 3 types of inherited metabolic disorders

A

Type 1 – Silent Disorders

Type 2 – Acute Metabolic Crises

Type 3 – Neurological Deterioration

43
Q

explain the inherited metabolic disorder, type 1 - silet disorder

A

Do not manifest in life-threatening crisis

Untreated could lead to brain damage developmental disabilities

Examples include IMDs associated with the metabolism of the aromatic acids

44
Q

explain Phenylketonuria (PKU)

A

Inability of the body to use the essential amino acid phenylalanine

Characterised by an elevated blood phenylalanine levels

3 different phenotypes:

  • Classic PKU - blood Phenylalanine levels of > 1200 µmol/l
  • Variant PKU - blood Phenylalanine levels of 600 – 1200 µmol/l
  • Mild Hyperphenylalanemia (HPA) - blood Phenylalanine levels of < 600 µmol/l
45
Q

explain Phenylalanine Hydroxylase (PAH) Mixed function oxidase

A

Catalyses the hydroxylation of phenylalanine, resulting in the formation of tyrosine

46
Q

what is the number of classic PKU incidence

A

1/10,000 – 20,000 Caucasian or Asian births

47
Q

how is classic pku inherited

A

Inherited as an autosomal recessive trait of a defective PAH gene

  • More than 500 different mutations at the PAH gene locus have been identified
  • Heterozygotes (1.5%) are normal
48
Q

explain metabolite profiles in classic pku

A

Carriers of Classic PKU have a reduced level of PAH, reflected as an increased level of phenylalanine in the blood and the brain and a reduced level of Tyrosine

Untreated blood phenylalanine levels >1200 µmol/L is neurotoxic

Accumulating Phe is metabolised via alternate routes, leading to phenylpyruvate and phenyllactate

Disruption of amino acid transport (Tyr and Trp) across the blood brain barrier, reduction in catecholamine biosynthesis and accumulation of toxic metabolites.

49
Q

explain mild pku

A

The cause is the same classical PKU, a mutation in the gene for Phenylalanine Hydroxylase however the result is not as severe

  • Less functional enzyme
  • Less of the functional enzyme
50
Q

explain variant pku

A

The mutation is not in Phenylalanine Hydroxylase but in Dihydrobiopterin Reductase, the enzyme that reduces and recycles BH2 for the oxidation of Phenylalanine

51
Q

explain diagnosis of Phenylketonuria

A

Early screening of neonates in most developed countries e.g. Guthrie test (bacterial inhibition test) most common

  • Guthrie Test:
    Neonatal Heel Prick test

Bacillus subtilis is grown on minimal culture media agar plates containing B-2-thienylalanine
This inhibits growth unless Phenylalanine is added

Neonatal blood is drawn onto a card, and a punch is made into that and placed onto the agar.
Should phenylalanine be present in a high concentration the bacteria will grow under the card

Useful for the diagnosis of a multitude of conditions.

Newer methods by tandem MS/MS to measure the concentration of Phe and the Phe/Tyr ratio

52
Q

explain the Phenylketonuria Symptoms

A

A musty odour on the breath, skin, and urine caused by the increased [phenylalanine]

Neurological problems that may include seizures

Eczema

Fair skin and blue eyes due to the lack of melanin

Microcephaly

Hyperactivity

Delayed development and intellectual disability
- If PKU not detected within the first month of life, then the delayed development and mental retardation becomes irreversible

Behavioural, emotional, and social problems

Psychiatric disorders

53
Q

explain treatment of pku through diet

A

Primarily by the restriction of Phe intake through natural protein restricted diets supplemented with phenylalanine free amino acid mixtures

British National Formulary outlines types of “Food for Special Diets” available within the NHS
- Such food preparations are regarded as drugs and include a range of protein liquid supplements and Tyrosine amino acid supplements

Ideally, gene therapy or enzyme replacement therapy should become available and is an area of active research

54
Q

explain the Treatment for PKU – BH4 cofactor approach

A

Some PKU sufferers benefit from oral tetrahydrobiopterin (BH4) administration
- BH4 responders

Stable, synthetic BH4 formulation has been approved by Food and Drug Administration

Available in tablet form as Kuvan (Sapropterin Dihydrochloride)
- Dosing of 20mg/kg required for the ingestion of up to 14 tablets per day
- Led to some non-compliance in a recent study

Treatment lowers the concentration of blood Phe concentrations

55
Q

what is alkaptonuria

A

Also known as ‘Black Urine Disease’

Autosomal recessive disease in which the enzyme Homogentisic acid oxidase is absent

Blood levels of homogentisic acid become extremely high and thus it is excreted in the urine

Urine samples darken with time as homogentisic acid oxidises to the black coloured alkapton, hence alkaptonuria

56
Q

what are the consequences of alkaptonuria

A

Homogentisic acid accumulation in tissues leads to:

Cartilage damage and ochronosis leading to lower back pain in child sufferers.
- Need for hip and knee replacement in young sufferers
- Ochronosis – yellow discolouration of the tissue seen microscopically

Heart valve abnormalities (aortic stenosis)

Kidney and prostate stones

Darkening of the sclera of the eyes

Ear wax exposed to the air turns red or black

57
Q

what are the treatments for Alkaptonuria

A

Large dosage of ascorbic acid (Vitamin C)

Dietary restriction of phenylalanine and tyrosine may be effective in children, but benefits in adults have not been demonstrated

The herbicide nitisinione inhibits p-hydroxyphyenylpyruvic acid oxidase and thus decreases the amount of homogentisic acid produced

  • Currently undergoing trials in various methods of administration
  • The main side effect is irritation of the cornea and is a concern that it will cause the symptoms of tyrosinemia because of the possible accumulation of tyrosine or other intermediates
58
Q

explain IMD Type 2 – Acute Metabolic Crisis

A

Life threatening in infancy

Children are protected in utero
- Maternal circulation which provides the missing product or removes the toxic substance

Example: Urea Cycle Disorders

59
Q

explain ammonia and the urea cycle

A

Ammonia is generated from a variety of sources in the body

  • It is a waste product of the deamination of amino acids
  • It is also produced in large quantities by gut bacteria

It is absorbed across the intestinal wall and found in high concentrations in the hepatic portal blood

It is produced by the metabolism of muscles and venous concentrations are higher than arterial

The Urea Cycle enables toxic ammonia molecules to be converted to the readily excreted and non-toxic urea

  • It has other metabolic benefits - important source of arginine, which is used in a variety of metabolic reactions
60
Q

what is urea

A

is the major disposal form of amino groups derived from amino acids and accounts for the majority of the nitrogen-containing components of urine

61
Q

where is urea produced and transported and why

A

Urea is produced in the liver and is transported in the blood to the kidneys for urinary excretion

62
Q

name the enzymes found in the mitochondria of the urea cycle

A

① Carbamyl phosphate synthase I

② Ornithine transcarbamylase

63
Q

name the enzymes found in the cytosol of the urea cycle

A

③ Arginosuccinate synthase

④ Arginosuccinate lyase

⑤ Arginase

64
Q

what happens if the urea cycle goes wrong

A

Defects of enzymes involved in the urea cycle lead to hyperammonaemia and an arginine deficiency, except in the case of arginase deficiency

65
Q

what is ammonia which is produced by the urea cycle going wrong

A

Ammonia is neurotoxic and damages the central nervous system, causing a variety of symptoms from drowsiness to death

66
Q

what enzymes are not present if there is a mitochondrial enzyme deficiency

A

① Carbamyl phosphate synthase I

② Ornithine transcarbamylase

67
Q

explain mitochondrial enzyme deficiencies

A

Represent the most severe of the Urea Cycle Disorders

Appear unaffected at birth

As hyperammonaemia progresses vomiting will begin after a few days, followed by respiratory distress, lethargy, and may slip into a coma

Untreated = Death

Treated = Regular Relapse, severe developmental disabilities

68
Q

explain Ornithine Transcarbamylase Deficiency

A

The most common urea cycle disease

It is X-linked, thus there is a variable phenotype in female heterozygotes depending on pattern of random X chromosome inactivation

Males are usually more severely affected

Characterised by orotic aciduria and hyperammonaemia

Amino acid abnormalities are mainly non-specific, i.e., increased glutamine and alanine, and decreased ornithine, arginine, and citrulline

69
Q

explain the cytosolic enzyme deficiency Citrullinaemia

A

no enzyme ③ Arginosuccinate synthase

Characterised by:
- Elevated Citrulline in plasma and urine
- Orotic acid in the urine
- Hyperammonaemia

Treatment is slightly easier because sufferers are able to incorporate some waste nitrogen into urea cycle intermediates

70
Q

explain the cytosolic enzyme deficiency Arginosuccinic aciduria

A

no enzyme ④ Arginosuccinate lyase

Characterised by elevations of argininosuccinate in plasma and urine

Renal excretion provides the body with route to excrete nitrogen, so hyperammonaemia is often mild and may be absent

71
Q

explain the cytosolic enzyme deficiency Hyperarginaemia

A

no enzyme ⑤ Arginase

It is characterised be elevations of arginine in plasma and urine, and orotic aciduria

Hyperammonaemia is variable and may only be mild or intermittent

However, the clinical picture is usually severe
- Patients may present with neonatal seizures and frequently suffer progressive neurological symptoms as they grow. This includes spastic diplegia, a subtype of cerebral palsy

72
Q

name the treatment of urea cycle diseases

A

Alternative pathway stimulation

Haemodialysis, in cases of acute, extreme hyperammonaemia

Stimulation of Carbamyl Phosphate Synthase by a synthetic cofactor

A low protein diet is a very common strategy to control chronic hyperammonaemia

Arginine supplementation in relevant disorders

Liver Transplantation

73
Q

explain the Urea Cycle Disease Treatment - Alternative pathway stimulation

A

Oral drugs that cause an increase in the excretion of glycine thereby depleting ammonia by stimulating the replacement synthesis of glycine using ammonia as a substrate

Most commonly used drugs:
- Benzoate
- Phenylbutyrate
- Phenylacetate

74
Q

explain IMD Type 3 – Progressive Neurological Deterioration

A

Early childhood
- Progressive loss of motor and cognitive skills

Infant
- Non-responsive state

Infant/Adolescence
- Death

75
Q

explain IMD type 3s Tay sachs disease

A

Lack of an enzyme called Hexosaminidase A

  • Gangliosides in neural tissue cannot be degraded
76
Q

what happens in tay sachs disease from the normal birth to the death

A

normal birth

lack of interaction/startle reflex

weak floppy, muscle blindness

seizures

shallow breathing

paralysis

death